Dr. Schwartz is internationally recognized for the innovative application of new technology in imaging to improve both clinical care and drug discovery. Renowned in the field of oncologic imaging, he is an authority on the development and validation of imaging biomarkers. His research has focused on new computational and functional techniques that utilize physiologic imaging and advanced image processing to assess and correlate imaging characteristics with molecular features of disease processes, in particular solid tumors of the chest, abdomen and pelvis. At MSKCC, Dr. Schwartz founded the Laboratory for Computational Image Analysis, which focuses on advanced image processing to quantitatively assess therapeutic efficacy in clinical care and drug discovery.
Dr. Schwartz has also achieved international recognition in the field of medical informatics. He was the principal collaborator with IBM in the development of continuous speech voice recognition for radiology reporting and with GE in the development of one of the first enterprise-wide Picture Archiving and Communications Systems (PACS).